Xmark Opportunity Partners, LLC
10% Owner

Xmark Opportunity Partners, LLC insider trades: Aeolus Pharmaceuticals (AOLS) stock buys and sales

10% Owner, Aeolus Pharmaceuticals Last trade Feb 19, 2013 84 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
73
Open-market trades
since 2007
3
Companies
last trade 2013

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Xmark Opportunity Partners, LLC reports to the SEC

Open-market buys and sales

73 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 19, 2013AOLS↓ Sell$592K
Oct 6, 2009AOLS↑ Buy$1.7M
Jun 29, 2009GENR↓ Sell$4K
Jun 5, 2009GENR↓ Sell$427K
Mar 30, 2009AOLS↑ Buy$1.5M
Dec 30, 2008AOLS↑ Buy$3K
Nov 21, 2008AOLS↑ Buy$13K
Oct 14, 2008AOLS↑ Buy$6K
Sep 29, 2008AOLS↑ Buy$6K
Sep 18, 2008AOLS↑ Buy$4K
Aug 18, 2008AOLS.OB↑ Buy$12K
Jun 20, 2008GENR↑ Buy$52K
Jun 18, 2008GENR↑ Buy$53K
Jun 4, 2008GENR↑ Buy$33K
May 30, 2008GENR↑ Buy$63K
May 27, 2008GENR↑ Buy$142K
May 19, 2008GENR↑ Buy$56K
May 14, 2008GENR↑ Buy$119K
Apr 29, 2008AOLS.OB↑ Buy$9K
Apr 15, 2008AOLS.OB↑ Buy$23K
Apr 3, 2008AOLS.OB↑ Buy$7K
Mar 24, 2008AOLS.OB↑ Buy$11K
Mar 12, 2008AOLS.OB↑ Buy$2K
Feb 28, 2008AOLS.OB↑ Buy$435
Feb 5, 2008AOLS.OB↑ Buy$12K
Jan 31, 2008AOLS.OB↑ Buy$7K
Jan 17, 2008AOLS.OB↑ Buy$13K
Dec 31, 2007AOLS.OB↑ Buy$12K
Dec 28, 2007AOLS.OB↑ Buy$11K
Dec 21, 2007GENR↑ Buy$291K
Dec 20, 2007GENR↑ Buy$212K
Dec 19, 2007AOLS.OB↑ Buy$13K
Dec 7, 2007AOLS.OB↑ Buy$26K
Dec 3, 2007AOLS.OB↑ Buy$29K
Nov 27, 2007AOLS.OB↑ Buy$23K
Nov 19, 2007AOLS.OB↑ Buy$24K
Nov 7, 2007AOLS.OB↑ Buy$12K
Nov 5, 2007AOLS.OB↑ Buy$31K
Oct 31, 2007AOLS.OB↑ Buy$15K
Oct 30, 2007AOLS.OB↑ Buy$9K
Oct 25, 2007AOLS.OB↑ Buy$23K
Oct 16, 2007AOLS.OB↑ Buy$21K
Oct 9, 2007AOLS.OB↑ Buy$17K
Oct 2, 2007AOLS.OB↑ Buy$11K
Sep 28, 2007AOLS.OB↑ Buy$17K
Sep 25, 2007GENR↑ Buy$164K
Sep 17, 2007GENR↑ Buy$6K
Sep 6, 2007GENR↑ Buy$55K
Sep 5, 2007GENR↑ Buy$82K
Aug 30, 2007GENR↑ Buy$114K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Xmark Opportunity Partners, LLC's insider trades

Xmark Opportunity Partners, LLC is a 10% owner of Aeolus Pharmaceuticals (AOLS). Since Apr 20, 2007, it has reported 70 open-market purchases worth $8.6M and 3 sales worth $1.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (30 filings), option exercises (2 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AOLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.